Preliminary Study on Hepatitis B Virus Nuclei Acid Vaccine with Interleukin-18 As Co-Stimulator

董菁,成军,王勤环,刘妍,王刚,施双双,李克,邵得志,斯崇文

DOI: https://doi.org/10.3760/j.issn:1000-6680.2002.03.005

2002-01-01

Abstract:Objective To construct plasmid pVR1012 M as nuclei acid vaccine for hepatitis B,was constructed to immunize mice with or without plasmid pcDNA 3.1 - IL 18 to identify the effect of Interleukin 18(IL 18). Methods Polymerase chain reaction method was used to amplify the PreS2 and S region of HBV and reconstruct plasmid pVR1012 M as nuclei acid vaccine. Plasmid pcDNA 3.1 - IL 18 was used as a co stimulator. Twenty five Balb/c mice were divided into 3 groups, group 1 immunized with 100 μg plasmid pVR1012 group 2 pVR1012 M,Group 3,pVR1012 M with pcDNA 3.1 - IL 18, respectively, every 2 weeks for 3 times. Anti HBs were detected in serum 2 weeks after each injection. Lactated ehydrogenase (LDH) cytotoxicity assay was done to analyze the cytotoxic T lymphocytes funciton. Results The positive rate and the antibody titer of serum from mice injected pVR1012 M increasing gradually with the increasing frequency of inoculation, while those from mice injected pVR1012 M and pcDNA 3.1 - IL 18(joint group) were lower than those injected with pVR1012 M alone (Difference after 3rd inoculation was significant, P0.05) . LDH assay results indicated that the cytotoxicity percent of joint group was higher than that of pVR1012 M group, but without significant difference. Conclusions pVR1012 M can induce both humoral and celluar immunity response specific for HBV in mice. IL 18 may down regulate the humoral and upregulate the cellular immunity response.